Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Non Operating Income (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Non Operating Income for 3 consecutive years, with -$2000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 60.0% to -$2000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 263.0% year-over-year, with the annual reading at -$14000.0 for FY2025, 108.92% down from the prior year.
  • Non Operating Income for Q4 2025 was -$2000.0 at Artiva Biotherapeutics, up from -$3000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $1.9 million in Q1 2025, with the low at -$1.8 million in Q4 2023.
  • Average Non Operating Income over 3 years is -$43545.5, with a median of -$3000.0 recorded in 2025.
  • The sharpest move saw Non Operating Income crashed 406.11% in 2024, then skyrocketed 251.61% in 2025.
  • Over 3 years, Non Operating Income stood at -$1.8 million in 2023, then skyrocketed by 99.72% to -$5000.0 in 2024, then skyrocketed by 60.0% to -$2000.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$2000.0, -$3000.0, and -$5000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.